- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00835835
Lokomat Treadmill Training Effects on MS Gait
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06112
- Mandell Center for Multiple Sclerosis at Mt. Sinai Rehabilitation Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Main Inclusion Criteria:
- Clinical diagnosis of MS
- EDSS level between 3.5-6.0
- Problems with ambulation
- able to ambulate 25 feet without an assistive device
Main Exclusion Criteria:
- Lower extremity injuries that limit range of motion or function
- Unable to demonstrate an understanding of the process of the study and or fully understand instructions in order to safely participate in the study and use study equipment
Body weight over 150 kg
- complete inclusion/exclusion criteria listed in consent form
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control group
The placebo group did not receive treatment during the matched period yet did undergo all assessments.
The MS Placebo group received equal treatment following the study intervention period.
|
No treatment used for comparison
Other Names:
|
Experimental: Combination Treadmill training group
Subjects randomized to Combination therapy received 20 minutes of Lokomat assisted treadmill training followed by up to 20 minutes of BWS treadmill training (without robotic assistance) twice a week.
|
walking
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Gait Parameters
Time Frame: Baseline, throughout study enrollment and 2 months follow-up
|
Baseline, throughout study enrollment and 2 months follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6 minute walk
Time Frame: Baseline, throughout study enrollment and 2 months follow-up
|
The 6 minute walk test is measured on a treadmill.
The subject is asked to indicate the most comfortable treadmill speed to the therapist.
The subject is instructed to walk as far as possible in 6 minutes and the total distance covered in 6 minutes is recorded.
A harness, without body-weight support, is attached for safety.
|
Baseline, throughout study enrollment and 2 months follow-up
|
MSQLI (Multiple Sclerosis Quality of Life Index)
Time Frame: Baseline, throughout study enrollment and 2 months follow-up
|
The MSQLI is a battery consisting of 10 individual scales providing a quality of life measure that is both generic and MS-specific (Fischer et al, 1999).
The MS quality of life index is a validated instrument used in accessing multiple aspects of quality of life for persons with MS.
It is a modification of the short-form health survey (SF-36) and requires about 30-45 minutes to complete.
|
Baseline, throughout study enrollment and 2 months follow-up
|
Timed 25-foot walk
Time Frame: Baseline, throughout study enrollment and 2 months follow-up
|
Will be collected over-ground and on a straight 25-foot GaitRite electronic mat.
The subject will be timed over the 25-foot distance both at their self-designated usual pace and at the fastest safe pace possible.
Data will be collected using a laptop computer.
The GaitRite system has software to calculate several measures including velocity, stride length, base width and number of steps.
|
Baseline, throughout study enrollment and 2 months follow-up
|
Frequency of Falls
Time Frame: Baseline, throughout study enrollment and 2 months follow-up
|
Falls will be recorded by the subjects onto a "Falls Calender" provided to the subjects.
Subjects will be given the following definition of a fall: "an event which results in a person coming to rest inadvertently on the ground or other lower level, and other than as a consequence of the following: sustaining a violent blow; loss of consciousness; sudden onset of paralysis, as in a stroke and an epileptic seizure" (Vellas 1992).
|
Baseline, throughout study enrollment and 2 months follow-up
|
FRT (Functional Reach Test)
Time Frame: Baseline, throughout study enrollment and 2 months follow-up
|
The Functional Reach test is a measure of balance and is the difference from arm's length and maximal forward reach.
The support case is fixed.
The test utilizes a 48-inch measuring device or "yardstick" for measuring functional reach.
Data is measured in inches (Duncan P. W. et al 1990).
|
Baseline, throughout study enrollment and 2 months follow-up
|
CDP (Computerized Dynamic Posturography)
Time Frame: Baseline, throughout study enrollment and 2 months follow-up
|
NeuroCom Smart Balance Master system. The use of CDP has allowed clinicians to objectively measure the postural components of balance (Liston 1996). CDP assesses sway by measuring shifts in the center of gravity (COG) as a person moves within the available limits of stability (LOS). Two types of tests will be used with CDP; they are the Sensory Organization Test (SOT) and the LOS test.
|
Baseline, throughout study enrollment and 2 months follow-up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Albert Lo, MD, PhD, Mandell Center for Multiple Sclerosis at Mount Sinai Rehabilitation Hospital
Publications and helpful links
General Publications
- Duncan PW, Weiner DK, Chandler J, Studenski S. Functional reach: a new clinical measure of balance. J Gerontol. 1990 Nov;45(6):M192-7. doi: 10.1093/geronj/45.6.m192.
- Fischer JS, LaRocca NG, Miller DM, Ritvo PG, Andrews H, Paty D. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler. 1999 Aug;5(4):251-9. doi: 10.1177/135245859900500410.
- Vellas B, Baumgartner RN, Wayne SJ, Conceicao J, Lafont C, Albarede JL, Garry PJ. Relationship between malnutrition and falls in the elderly. Nutrition. 1992 Mar-Apr;8(2):105-8.
- Liston RA, Brouwer BJ. Reliability and validity of measures obtained from stroke patients using the Balance Master. Arch Phys Med Rehabil. 1996 May;77(5):425-30. doi: 10.1016/s0003-9993(96)90028-3.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AL0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Usual Care - no active intervention
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedDepression | Type2 DiabetesUnited States
-
University of Alabama at BirminghamNational Institute of Nursing Research (NINR)CompletedStroke | Sepsis | Cancer | Pulmonary Disease | Hepatic Disease | Cardiac Disease | Renal Disease | Neuro-Degenerative DiseaseUnited States
-
French Red CrossInstitut National de la Santé Et de la Recherche Médicale, France; University... and other collaboratorsRecruitingPhysical Activity | Growth | Diet | Sedentary Behavior | InfantFrance
-
The University of Hong KongShenzhen Children's HospitalRecruiting
-
University of NottinghamNational Institute for Health Research, United KingdomCompletedPhysical Activity | Falls Prevention
-
University of New MexicoCompletedKidney ReplacementUnited States
-
University of Colorado, DenverAmerican Heart AssociationCompletedPatient Engagement | Heart Failure With Reduced Ejection Fraction | Patient Activation | Medication OptimizationUnited States
-
The University of Texas Health Science Center,...Cancer Prevention Research Institute of TexasCompletedCervical Cancer | Breast CancerUnited States
-
Gerencia de Atención Primaria, MadridInstituto de Salud Carlos IIICompletedTobacco Use CessationSpain
-
Cambridge Health AllianceNational Institute of Mental Health (NIMH)RecruitingResilience, Psychological | Screening | Health Equity | Community Mental Health Services | Adolescent Well BeingUnited States